Leukemia, Mast-Cell: Clinical Trials

5 trials for Leukemia, Mast-Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 4, Unknown 1

Follow Leukemia, Mast-Cell: new trials by email Literature Review of Leukemia, Mast-Cell trials Research Report on Leukemia, Mast-Cell

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
ketamine hydrochloride, pharmacogenomic studies, questionnaire administration - Cancer
Phase 3UnknownUniversity of Glasgow2142009-04-012011-05-13
American Ginseng in Treating Patients With Fatigue Caused by Cancer
American ginseng, placebo - Chronic Myeloproliferative Disorders, Fatigue
Phase 3CompletedAlliance for Clinical Trials in Oncology3642008-10-012017-02-09
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
educational intervention - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Phase 3CompletedCase Comprehensive Cancer Center5832008-04-012020-07-27
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
darbepoetin alfa, ferrous sulfate, sodium ferric gluconate complex in sucrose - Anemia, Leukemia
Phase 3CompletedMayo Clinic5022006-01-012011-05-17
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
educational intervention, Titrated pain management, questionnaire administration - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Phase 3CompletedVanderbilt-Ingram Cancer Center982005-05-012012-09-06

Narrower conditions

Burkitt Lymphoma (5)  ·  Hodgkin Disease (5)  ·  Immunoblastic Lymphadenopathy (5)  ·  Immunoglobulin Light-chain Amyloidosis (5)  ·  Leukemia, Biphenotypic, Acute (5)  ·  Leukemia, Hairy Cell (5)  ·  Leukemia, Large Granular Lymphocytic (5)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (5)  ·  Leukemia, Prolymphocytic (5)  ·  Lymphoma, B-Cell, Marginal Zone (5)  ·  Lymphoma, Extranodal NK-T-Cell (5)  ·  Lymphoma, Follicular (5)  ·  Lymphoma, Large B-Cell, Diffuse (5)  ·  Lymphoma, Large-Cell, Anaplastic (5)

Broader conditions

Amyloidosis (5)  ·  Blood Protein Disorders (5)  ·  Cardiovascular Diseases (5)  ·  Chronic Disease (5)  ·  DNA Virus Infections (5)  ·  Disease Attributes (5)  ·  Epstein-Barr Virus Infections (5)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Hemorrhagic Disorders (5)  ·  Hemostatic Disorders (5)  ·  Herpesviridae Infections (5)  ·  Immune System Diseases (5)  ·  Immunoproliferative Disorders (5)  ·  Infections (5)

Interventions

Early Intervention, Educational (2)  ·  Asian ginseng (1)  ·  Darbepoetin alfa (1)  ·  Ketamine (1)  ·  Pharmacogenomic Testing (1)  ·  Sucrose (1)  ·  ferric gluconate (1)  ·  ferrous sulfate (1)

Sponsors

Alliance for Clinical Trials in Oncology (1)  ·  Case Comprehensive Cancer Center (1)  ·  Mayo Clinic (1)  ·  University of Glasgow (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United States (4)  ·  United Kingdom (1)

Top investigators

Barry J.A. Laird, MD (1)  ·  Charles L. Loprinzi, MD (1)  ·  Debra Barton, RN, PhD, AOCN, FAAN (1)  ·  Marie T. Fallon (1)  ·  Nancy Wells, DNSc, RN (1)  ·  Neal J. Meropol, MD (1)  ·  Tom R. Fitch, M.D. (1)

Results publications

PMID 26700120, PMID 26700123

NIH funding

P30CA015083 (1), P30CA068485 (1), R01CA127655 (1)